KIM Hyun;RAQUALIA PHARMA INC.;LEE Ha Jin;CJ HEALTHCARE CORPORATION;PARK Jie Eun;TAKAHASHI Nobuyuki;TAJIMI Masaomi;Kim Bong Tae;NAM Ji Yeon;SONG Geun Seog;RYU Shin Young;KOIZUMI Shinichi
发明人:
LEE Ha Jin,Kim Bong Tae,KIM Hyun,NAM Ji Yeon,PARK Jie Eun,SONG Geun Seog,RYU Shin Young,KOIZUMI Shinichi,TAKAHASHI Nobuyuki,TAJIMI Masaomi
申请号:
IL25612717
公开号:
IL256127D0
申请日:
2017.12.05
申请国别(地区):
IL
年份:
2018
代理人:
摘要:
The present invention relates to a use of benzimidazole derivative compounds for improvement and treatment of nocturnal acid breakthrough (NAB). The benzimidazole derivative compounds can more effectively prevent and treat gastric acid-related diseases by effectively improving and treating nocturnal nocturnal acid breakthrough symptoms.